S 660 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act relative to the care and treatment of patients with mitochondrial disease

This Massachusetts bill mandates that state employee health plans and all private health insurance policies issued within the state cover treatments for mitochondrial disease. Specifically, it requires coverage for vitamin and nutritional supplements, including CoEnzyme Q10, various B vitamins, Vitamin C, Vitamin E, Vitamin K1, and L-Carnitine. The law applies to a wide range of insurance types, including those for government workers, private group plans, individual policies, and health maintenance organizations. By amending multiple existing chapters of state law, the bill ensures that anyone with this condition has access to these specific treatments regardless of their insurance source.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action May 9, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
2
Mar 11, 2024
Senate · Reported by committee
Bill reported favorably by committee and referred to the committee on Health Care Financing
Feb 16, 2023
House · Passed
House concurred
Feb 16, 2023
Senate · Referred to committee
Referred to the committee on Financial Services
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of John Keenan
John Keenan
DDemocratic
MA
Norfolk and Plymouth